Identification of New Potent Acetylcholinesterase Inhibitors Using Virtual Screening and in vitro Approaches

EH Mokrani, A Bensegueni, L Chaput… - Molecular …, 2019 - Wiley Online Library
Acetylcholinesterase (AChE) is currently the most favorable target for the symptomatic
treatment and reduction of Alzheimer's disease (AD). In order to identify new potent …
被引用次数：15 相关文章

Identification of New Potent Acetylcholinesterase Inhibitors Using Virtual Screening and in vitro Approaches.

EH Mokrani, A Bensegueni, L Chaput… - Molecular …, 2019 - search.ebscohost.com
Acetylcholinesterase (AChE) is currently the most favorable target for the symptomatic
treatment and reduction of Alzheimer's disease (AD). In order to identify new potent …

Identification of New Potent Acetylcholinesterase Inhibitors Using Virtual Screening and in vitro Approaches.

EH Mokrani, A Bensegueni, L Chaput… - Molecular …, 2019 - europepmc.org
Acetylcholinesterase (AChE) is currently the most favorable target for the symptomatic
treatment and reduction of Alzheimer's disease (AD). In order to identify new potent …

Identification of New Potent Acetylcholinesterase Inhibitors Using Virtual Screening and in vitro Approaches

EH Mokrani, A Bensegueni, L Chaput… - Molecular …, 2019 - pubmed.ncbi.nlm.nih.gov
Acetylcholinesterase (AChE) is currently the most favorable target for the symptomatic
treatment and reduction of Alzheimer's disease (AD). In order to identify new potent …

Identification of New Potent Acetylcholinesterase Inhibitors Using Virtual Screening and in vitro Approaches

EH Mokrani, A Bensegueni, L Chaput… - Molecular …, 2019 - hal.science
Acetylcholinesterase (AChE) is currently the most favorable target for the symptomatic
treatment and reduction of Alzheimer's disease (AD). In order to identify new potent …